The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Controlled Clinical Trials

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Controlled Clinical Trials


Psychiatry related information on Controlled Clinical Trials


High impact information on Controlled Clinical Trials

  • Propranolol may not be indicated for the prophylaxis of variceal rebleeding in such patients, and we advocate that its use be limited at present to controlled clinical trials [11].
  • Whether or not lower doses or intermittent fluoride therapy will prove to be effective in patients who have already sustained fractures, is also being actively investigated in controlled clinical trials [12].
  • The concept that GH "replacement" would materially benefit the daily function of older men and women finds little support in the results of the controlled clinical trials that have been reported [13].
  • In controlled clinical trials, nicotine replacement therapy (NRT) and the antidepressant bupropion have been shown to significantly increase cessation rates only for moderate to heavy smokers (> or = 15 cigarettes/d) [14].
  • STUDY SELECTION: Included studies were randomized, controlled clinical trials comparing interferon and ribavirin with interferon alone and reporting virological and biochemical outcomes after a follow-up period [15].

Chemical compound and disease context of Controlled Clinical Trials


Biological context of Controlled Clinical Trials


Anatomical context of Controlled Clinical Trials


Associations of Controlled Clinical Trials with chemical compounds


Gene context of Controlled Clinical Trials


Analytical, diagnostic and therapeutic context of Controlled Clinical Trials


  1. Association of adrenocorticosteroid therapy and peptic-ulcer disease. Messer, J., Reitman, D., Sacks, H.S., Smith, H., Chalmers, T.C. N. Engl. J. Med. (1983) [Pubmed]
  2. Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. Major, P., Lortholary, A., Hon, J., Abdi, E., Mills, G., Menssen, H.D., Yunus, F., Bell, R., Body, J., Quebe-Fehling, E., Seaman, J. J. Clin. Oncol. (2001) [Pubmed]
  3. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Rudick, R.A., Fisher, E., Lee, J.C., Simon, J., Jacobs, L. Neurology (1999) [Pubmed]
  4. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Plosker, G.L., McTavish, D. Drugs (1994) [Pubmed]
  5. Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Clissold, S.P., Sorkin, E.M., Goa, K.L. Drugs (1989) [Pubmed]
  6. Projected coronary heart disease risk benefit with ezetimibe. Davies, G.M., Cook, J.R., Erbey, J., Alemao, E., Veltri, E.P. Atherosclerosis (2005) [Pubmed]
  7. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Montgomery, S.A., Thal, L.J., Amrein, R. International clinical psychopharmacology. (2003) [Pubmed]
  8. A review of clinical trials comparing HMG-CoA reductase inhibitors. Illingworth, D.R., Tobert, J.A. Clinical therapeutics. (1994) [Pubmed]
  9. Dose and frequency of interferon treatment matter--INCOMIN and OPTIMS. Durelli, L. J. Neurol. (2003) [Pubmed]
  10. Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. Biederman, J., McDonnell, M.A., Wozniak, J., Spencer, T., Aleardi, M., Falzone, R., Mick, E. CNS spectrums. (2005) [Pubmed]
  11. Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. Burroughs, A.K., Jenkins, W.J., Sherlock, S., Dunk, A., Walt, R.P., Osuafor, T.O., Mackie, S., Dick, R. N. Engl. J. Med. (1983) [Pubmed]
  12. Sodium fluoride therapy of postmenopausal osteoporosis. Kleerekoper, M., Mendlovic, D.B. Endocr. Rev. (1993) [Pubmed]
  13. Growth hormone as therapy for older men and women. Marcus, R., Hoffman, A.R. Annu. Rev. Pharmacol. Toxicol. (1998) [Pubmed]
  14. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. Pierce, J.P., Gilpin, E.A. JAMA (2002) [Pubmed]
  15. Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta-analysis of randomized trials. Cummings, K.J., Lee, S.M., West, E.S., Cid-Ruzafa, J., Fein, S.G., Aoki, Y., Sulkowski, M.S., Goodman, S.N. JAMA (2001) [Pubmed]
  16. The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia. Moore, R.D., Smith, C.R., Lietman, P.S. J. Infect. Dis. (1984) [Pubmed]
  17. Drug antioxidant effects. A basis for drug selection? Halliwell, B. Drugs (1991) [Pubmed]
  18. Cetirizine. A review of its pharmacological properties and clinical potential in allergic rhinitis, pollen-induced asthma, and chronic urticaria. Campoli-Richards, D.M., Buckley, M.M., Fitton, A. Drugs (1990) [Pubmed]
  19. Seasonal variation in the incidence of deep vein thrombosis. Lawrence, J.C., Xabregas, A., Gray, L., Ham, J.M. The British journal of surgery. (1977) [Pubmed]
  20. The impact of new biologicals in the treatment of rheumatoid arthritis. Weaver, A.L. Rheumatology (Oxford, England) (2004) [Pubmed]
  21. Supportive therapy in COPD. Petty, T.L. Chest (1998) [Pubmed]
  22. Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? The Heart Muscle Disease Study Group. DiLenarda, A., Gregori, D., Sinagra, G., Lardieri, G., Perkan, A., Pinamonti, B., Salvatore, L., Secoli, G., Zecchin, M., Camerini, F. J. Card. Fail. (1996) [Pubmed]
  23. Criteria for improvement in rheumatoid arthritis: alternatives to the American College of Rheumatology 20. Albert, D.A., Huang, G., Dubrow, G., Brensinger, C.M., Berlin, J.A., Williams, H.J. J. Rheumatol. (2004) [Pubmed]
  24. Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases. Gemzell-Danielsson, K., Ostlund, E. Acta obstetricia et gynecologica Scandinavica. (2000) [Pubmed]
  25. The use of dexamethasone in the prevention of postextubation stridor in pediatric patients in PICU/NICU settings: an analytical review. Jansaithong, J. Journal of the Society of Pediatric Nurses : JSPN. (2001) [Pubmed]
  26. Emerging role of cephalosporins in bacterial meningitis. Nelson, J.D. Am. J. Med. (1985) [Pubmed]
  27. Effects of sevelamer and calcium on coronary artery calcification in patients new to dialysis: time for better controlled clinical trials. Qunibi, W.Y. Kidney Int. (2006) [Pubmed]
  28. Neutrophil activation: an alternative to prostaglandin inhibition as the mechanism of action for NSAIDs. Altman, R.D. Semin. Arthritis Rheum. (1990) [Pubmed]
  29. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation. Cassano, W.F. Bone Marrow Transplant. (1991) [Pubmed]
  30. Pharmacological approaches to the therapy of chronic fatigue syndrome. McCluskey, D.R. Ciba Found. Symp. (1993) [Pubmed]
  31. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. Strain, E.C., Bigelow, G.E., Liebson, I.A., Stitzer, M.L. JAMA (1999) [Pubmed]
  32. Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-Infected Patients. Sande, M.A., Carpenter, C.C., Cobbs, C.G., Holmes, K.K., Sanford, J.P. JAMA (1993) [Pubmed]
  33. Antibiotic activity in surgical incisions. The basis of prophylaxis in selected operations. Polk, H.C., Trachtenberg, L., Finn, M.P. JAMA (1980) [Pubmed]
  34. Tamoxifen and benign breast problems. Fentiman, I.S., Powles, T.J. Lancet (1987) [Pubmed]
  35. Advances in drug therapy for inflammatory bowel disease. Peppercorn, M.A. Ann. Intern. Med. (1990) [Pubmed]
  36. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. van den Borne, B.E., Dijkmans, B.A., de Rooij, H.H., le Cessie, S., Verweij, C.L. J. Rheumatol. (1997) [Pubmed]
  37. Interleukin-1 receptor antagonist transiently impairs antibacterial defense but not survival in murine pneumococcal pneumonia. Rijneveld, A.W., Florquin, S., Speelman, P., Edwards, C.K., Dinarello, C.A., van der Poll, T. Eur. Cytokine Netw. (2003) [Pubmed]
  38. Hereditary breast cancer. Identifying and managing BRCA1 and BRCA2 carriers. Heisey, R.E., Carroll, J.C., Warner, E., McCready, D.R., Goel, V. Canadian family physician Médecin de famille canadien. (1999) [Pubmed]
  39. Glatiramer acetate (Copaxone) therapy for multiple sclerosis. Dhib-Jalbut, S. Pharmacol. Ther. (2003) [Pubmed]
  40. Effects of fibrate compounds on expression of plasminogen activator inhibitor-1 by cultured endothelial cells. Nilsson, L., Takemura, T., Eriksson, P., Hamsten, A. Arterioscler. Thromb. Vasc. Biol. (1999) [Pubmed]
  41. Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Mannucci, P.M. Blood (1988) [Pubmed]
  42. Multiple-dose ciprofloxacin kinetics in normal subjects. Aronoff, G.E., Kenner, C.H., Sloan, R.S., Pottratz, S.T. Clin. Pharmacol. Ther. (1984) [Pubmed]
  43. Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers. Standiford, H.C., Drusano, G.L., Bustamante, C.I., Rivera, G., Forrest, A., Tatem, B., Leslie, J., Moody, M. Antimicrob. Agents Chemother. (1986) [Pubmed]
  44. MorphiDex (morphine sulfate/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance. Galer, B.S., Lee, D., Ma, T., Nagle, B., Schlagheck, T.G. Pain (2005) [Pubmed]
  45. Meta-analysis of rizatriptan efficacy in randomized controlled clinical trials. Ferrari, M.D., Loder, E., McCarroll, K.A., Lines, C.R. Cephalalgia : an international journal of headache. (2001) [Pubmed]
WikiGenes - Universities